Nasal mucosal epithelial cells form the first line of defense by maintaining a barrier to restrict potentially harmful airborne substances and pathogens. To aid in host defense, specialized epithelial cells in submucosal glands as well as on the mucosal surface secrete mucous that helps to immobilize pathogens and other harmful substances. Beneath this mucous blanket resides an aqueous surface liquid layer, which allows proper ciliary function to clear mucous and entrapped pathogens. In concert with maintenance of a physical barrier, airway epithelium secretes dozens of antimicrobial peptides and proteins that become incorporated into the mucous and aqueous lining fluids1, 2. It has become clear that proper functioning of the epithelium is essential for suppressing the growth of pathogenic organisms and promoting healthy upper airway physiology. Dysfunction in innate immune expression of host defense molecules has been linked to many airway diseases3-8. Surprisingly, the regional distribution of important epithelial derived antimicrobial proteins secreted into upper airways has not been studied in detail. In this study, we analyzed the expression of select antimicrobial proteins that are known to be secreted into the lining fluids of the upper airways in two different anatomical sites of the sinonasal mucosa in healthy human subjects, namely the inferior region (inferior turbinate - IT), and the superior region (uncinate tissue - UT). We chose IT, as it is the proximal point of contact of inhaled air containing particulate matter and potential pathogens. Moreover, studies of CRS and other diseases of the upper airways routinely use IT tissue as a control tissue to make comparisons with nasal polyps. UT was chosen for its important role in the drainage pathways of maxillary, frontal and anterior ethmoid sinuses. We chose to study the expression of S100A7 (S100 family), hBD2 (β-Defensin family), SPLUNC1 (PLUNC family), and lactoferrin, as they represent broad families of antimicrobial proteins, which are either constitutively present or induced by inflammation triggered by pathogens and collectively have antimicrobial effects against a variety of pathogens (bacteria, fungi and viruses). Sinonasal tissue samples from IT and UT were collected from subjects undergoing surgery to correct non-inflammatory conditions, including facial anatomical defects (deformity, trauma etc.), to improve airflow and during the course of skull base surgery to remove tumors. The subjects were not diagnosed with any upper or lower airway diseases at the time of sample collection. Detailed patient characteristics are provided in table EI. The Investigational Review Board of Northwestern University approved all methods for the present study, and all patients provided informed consent. At the time of surgery, tissues and nasal epithelial scraping cells were collected and stored for further analysis. Tissue samples and epithelial cells were analyzed for mRNA expression by real time PCR. Protein expression and localization were analyzed using ELISA and immunohistochemistry, respectively. AB/PAS staining was performed to characterize the glandular differences between IT and UT. Details of the methods used can be found in the online repository and our other publications5, 7.